Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib

dbGaP Study Accession: phs002705.v1.p1

Study
phs002705.v1.p1

Variable Name and Accession: Variable Name: IS_TUMOR
Variable Accession: phv00495865.v1.p1
Variable belongs to dataset: pht011842.v1.p1 : CLL_Reversal_Ibrutinib_Sample_Attributes: This sample attributes data table includes body site, analyte type, tumor status, histological type, and tumor treatment.
Variable Description: Tumor status
Statistical Summary